Biologics discovery and development remains a hot topic not only for the creation of novel antibody based therapies but also as the raw material for the emerging adoptive cell therapy market. There are several areas in biologics discovery where multiple critical process steps and the analysis of the resulting data cause bottlenecks in the overall workflow. The Intellicyt® iQue Screener PLUS platform addresses these issues and helps streamline and optimize this workflow:
Watch this webinar to learn more